APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albendazole Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Albendazole Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchAlbendazole Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Tablets Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Albendazole Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Tablets Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Tablets Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Albendazole Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Albendazole Tablets include Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Zhejiang Anbet Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd., Sancai Shiqi Pharmaceutical Co., Ltd., Ningxia Qiyuan National Pharmaceutical Co., Ltd., Longhui Pharmaceutical Co., Ltd., Huazhong Pharmaceutical Co., Ltd. and Hubei Ruihua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Albendazole Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Albendazole Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albendazole Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albendazole Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Albendazole Tablets Segment by Company

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Shanghai Xinya Pharmaceutical Minhang Co., Ltd.

Sancai Shiqi Pharmaceutical Co., Ltd.

Ningxia Qiyuan National Pharmaceutical Co., Ltd.

Longhui Pharmaceutical Co., Ltd.

Huazhong Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

Hubei Meibao Pharmaceutical Co., Ltd.

Hubei Kelun Pharmaceutical Co., Ltd.

Hubei Guangji Pharmaceutical Co., Ltd.

Henan Runhong Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

Guangzhou Kanghe Pharmaceutical Co., Ltd.

Anhui Shengying Pharmaceutical Co., Ltd.

Teva

Sequent Scientific

Salius Pharma

Lasa Supergenerics Limited

K.A. Malle Pharmaceuticals

GlaxoSmithKline

Fredun Pharmaceuticals Ltd

AdvaCare Pharma

Aden

Albendazole Tablets Segment by Type

0.1g

0.2g

Albendazole Tablets Segment by Application

For Veterinary Use

For Human Use

Albendazole Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albendazole Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albendazole Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Albendazole Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Albendazole Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Albendazole Tablets Industry Trends Table 2. Albendazole Tablets Industry Drivers Table 3. Albendazole Tablets Industry Opportunities and Challenges Table 4. Albendazole Tablets Industry Restraints Table 5. Global Albendazole Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Albendazole Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Albendazole Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Albendazole Tablets Sales Market Share by Manufacturers Table 9. Global Albendazole Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Albendazole Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Albendazole Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Albendazole Tablets Manufacturers, Product Type & Application Table 13. Global Albendazole Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Albendazole Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.1g Table 17. Major Manufacturers of 0.2g Table 18. Global Albendazole Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Albendazole Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Albendazole Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Albendazole Tablets Sales Market Share by Type (2021-2026) Table 22. Global Albendazole Tablets Sales Market Share by Type (2027-2032) Table 23. Global Albendazole Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Albendazole Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Albendazole Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Albendazole Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Albendazole Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of For Veterinary Use Table 29. Major Manufacturers of For Human Use Table 30. Global Albendazole Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Albendazole Tablets Sales by Application (2021-2026) & (K Units) Table 32. Global Albendazole Tablets Sales by Application (2027-2032) & (K Units) Table 33. Global Albendazole Tablets Sales Market Share by Application (2021-2026) Table 34. Global Albendazole Tablets Sales Market Share by Application (2027-2032) Table 35. Global Albendazole Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Albendazole Tablets Revenue by Application (2021-2026) & (K Units) Table 37. Global Albendazole Tablets Revenue by Application (2027-2032) & (K Units) Table 38. Global Albendazole Tablets Revenue Market Share by Application (2021-2026) Table 39. Global Albendazole Tablets Revenue Market Share by Application (2027-2032) Table 40. Global Albendazole Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Albendazole Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Albendazole Tablets Sales Market Share by Region (2021-2026) Table 43. Global Albendazole Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Albendazole Tablets Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 47. North America Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 48. Europe Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 50. Europe Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 57. Global Albendazole Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Albendazole Tablets Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Albendazole Tablets Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Albendazole Tablets Revenue Market Share by Region (2021-2026) Table 61. Global Albendazole Tablets Revenue Market Share by Region (2027-2032) Table 62. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 63. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 64. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Product Portfolio Table 66. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Development Table 67. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information Table 68. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview Table 69. Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 71. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Development Table 72. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 73. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 74. Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 76. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Development Table 77. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information Table 78. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview Table 79. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Product Portfolio Table 81. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Development Table 82. Sancai Shiqi Pharmaceutical Co., Ltd. Company Information Table 83. Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview Table 84. Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 86. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Development Table 87. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Company Information Table 88. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Business Overview Table 89. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 91. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Recent Development Table 92. Longhui Pharmaceutical Co., Ltd. Company Information Table 93. Longhui Pharmaceutical Co., Ltd. Business Overview Table 94. Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 96. Longhui Pharmaceutical Co., Ltd. Recent Development Table 97. Huazhong Pharmaceutical Co., Ltd. Company Information Table 98. Huazhong Pharmaceutical Co., Ltd. Business Overview Table 99. Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 101. Huazhong Pharmaceutical Co., Ltd. Recent Development Table 102. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information Table 103. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview Table 104. Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 106. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Development Table 107. Hubei Meibao Pharmaceutical Co., Ltd. Company Information Table 108. Hubei Meibao Pharmaceutical Co., Ltd. Business Overview Table 109. Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 111. Hubei Meibao Pharmaceutical Co., Ltd. Recent Development Table 112. Hubei Kelun Pharmaceutical Co., Ltd. Company Information Table 113. Hubei Kelun Pharmaceutical Co., Ltd. Business Overview Table 114. Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 116. Hubei Kelun Pharmaceutical Co., Ltd. Recent Development Table 117. Hubei Guangji Pharmaceutical Co., Ltd. Company Information Table 118. Hubei Guangji Pharmaceutical Co., Ltd. Business Overview Table 119. Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 121. Hubei Guangji Pharmaceutical Co., Ltd. Recent Development Table 122. Henan Runhong Pharmaceutical Co., Ltd. Company Information Table 123. Henan Runhong Pharmaceutical Co., Ltd. Business Overview Table 124. Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 126. Henan Runhong Pharmaceutical Co., Ltd. Recent Development Table 127. Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information Table 128. Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview Table 129. Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 131. Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Development Table 132. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information Table 133. Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview Table 134. Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 136. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Development Table 137. Anhui Shengying Pharmaceutical Co., Ltd. Company Information Table 138. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview Table 139. Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 141. Anhui Shengying Pharmaceutical Co., Ltd. Recent Development Table 142. Teva Company Information Table 143. Teva Business Overview Table 144. Teva Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Teva Albendazole Tablets Product Portfolio Table 146. Teva Recent Development Table 147. Sequent Scientific Company Information Table 148. Sequent Scientific Business Overview Table 149. Sequent Scientific Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Sequent Scientific Albendazole Tablets Product Portfolio Table 151. Sequent Scientific Recent Development Table 152. Salius Pharma Company Information Table 153. Salius Pharma Business Overview Table 154. Salius Pharma Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Salius Pharma Albendazole Tablets Product Portfolio Table 156. Salius Pharma Recent Development Table 157. Lasa Supergenerics Limited Company Information Table 158. Lasa Supergenerics Limited Business Overview Table 159. Lasa Supergenerics Limited Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Lasa Supergenerics Limited Albendazole Tablets Product Portfolio Table 161. Lasa Supergenerics Limited Recent Development Table 162. K.A. Malle Pharmaceuticals Company Information Table 163. K.A. Malle Pharmaceuticals Business Overview Table 164. K.A. Malle Pharmaceuticals Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. K.A. Malle Pharmaceuticals Albendazole Tablets Product Portfolio Table 166. K.A. Malle Pharmaceuticals Recent Development Table 167. GlaxoSmithKline Company Information Table 168. GlaxoSmithKline Business Overview Table 169. GlaxoSmithKline Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. GlaxoSmithKline Albendazole Tablets Product Portfolio Table 171. GlaxoSmithKline Recent Development Table 172. Fredun Pharmaceuticals Ltd Company Information Table 173. Fredun Pharmaceuticals Ltd Business Overview Table 174. Fredun Pharmaceuticals Ltd Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 175. Fredun Pharmaceuticals Ltd Albendazole Tablets Product Portfolio Table 176. Fredun Pharmaceuticals Ltd Recent Development Table 177. AdvaCare Pharma Company Information Table 178. AdvaCare Pharma Business Overview Table 179. AdvaCare Pharma Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 180. AdvaCare Pharma Albendazole Tablets Product Portfolio Table 181. AdvaCare Pharma Recent Development Table 182. Aden Company Information Table 183. Aden Business Overview Table 184. Aden Albendazole Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 185. Aden Albendazole Tablets Product Portfolio Table 186. Aden Recent Development Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Albendazole Tablets Distributors List Table 190. Albendazole Tablets Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Albendazole Tablets Product Image Figure 2. Global Albendazole Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albendazole Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Albendazole Tablets Sales (2021-2032) & (K Units) Figure 5. Global Albendazole Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Albendazole Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.1g Image Figure 9. 0.2g Image Figure 10. Global Albendazole Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Albendazole Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Albendazole Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Albendazole Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Albendazole Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Albendazole Tablets Revenue Market Share by Type (2021-2032) Figure 16. For Veterinary Use Image Figure 17. For Human Use Image Figure 18. Global Albendazole Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Albendazole Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Albendazole Tablets Sales Market Share by Application (2021-2032) Figure 21. Global Albendazole Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Albendazole Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Albendazole Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 26. U.S. Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 31. Germany Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 38. China Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 46. Brazil Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Albendazole Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Albendazole Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Albendazole Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Albendazole Tablets Revenue (2021-2032) & (US$ Million) Figure 57. North America Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Albendazole Tablets Revenue (2021-2032) & (US$ Million) Figure 59. Europe Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Albendazole Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Albendazole Tablets Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Albendazole Tablets Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Albendazole Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • For Veterinary Use
  • For Human Use
Companies covered
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  • Zhejiang Anbet Pharmaceutical Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  • Sancai Shiqi Pharmaceutical Co., Ltd.
  • Ningxia Qiyuan National Pharmaceutical Co., Ltd.
  • Longhui Pharmaceutical Co., Ltd.
  • Huazhong Pharmaceutical Co., Ltd.
  • Hubei Ruihua Pharmaceutical Co., Ltd.
  • Hubei Meibao Pharmaceutical Co., Ltd.
  • Hubei Kelun Pharmaceutical Co., Ltd.
  • Hubei Guangji Pharmaceutical Co., Ltd.
  • Henan Runhong Pharmaceutical Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Co., Ltd.
  • Guangzhou Kanghe Pharmaceutical Co., Ltd.
  • Anhui Shengying Pharmaceutical Co., Ltd.
  • Teva
  • Sequent Scientific
  • Salius Pharma
  • Lasa Supergenerics Limited
  • K.A. Malle Pharmaceuticals
  • GlaxoSmithKline
  • Fredun Pharmaceuticals Ltd
  • AdvaCare Pharma
  • Aden

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Albendazole Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Albendazole Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Albendazole Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Albendazole Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Albendazole Tablets Market Dynamics
  1. 2.1 Albendazole Tablets Industry Trends
  2. 2.2 Albendazole Tablets Industry Drivers
  3. 2.3 Albendazole Tablets Industry Opportunities and Challenges
  4. 2.4 Albendazole Tablets Industry Restraints
3 Albendazole Tablets Market by Manufacturers
  1. 3.1 Global Albendazole Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Albendazole Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Albendazole Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Albendazole Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albendazole Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Albendazole Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Albendazole Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albendazole Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albendazole Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albendazole Tablets Tier 1, Tier 2, and Tier 3
4 Albendazole Tablets Market by Type
  1. 4.1 Albendazole Tablets Type Introduction
  2. 4.1.1 0.1g
  3. 4.1.2 0.2g
  4. 4.2 Global Albendazole Tablets Sales by Type
  5. 4.2.1 Global Albendazole Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Albendazole Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Albendazole Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Albendazole Tablets Revenue by Type
  9. 4.3.1 Global Albendazole Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Albendazole Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Albendazole Tablets Revenue Market Share by Type (2021-2032)
5 Albendazole Tablets Market by Application
  1. 5.1 Albendazole Tablets Application Introduction
  2. 5.1.1 For Veterinary Use
  3. 5.1.2 For Human Use
  4. 5.2 Global Albendazole Tablets Sales by Application
  5. 5.2.1 Global Albendazole Tablets Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Albendazole Tablets Sales by Application (2021-2032)
  7. 5.2.3 Global Albendazole Tablets Sales Market Share by Application (2021-2032)
  8. 5.3 Global Albendazole Tablets Revenue by Application
  9. 5.3.1 Global Albendazole Tablets Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Albendazole Tablets Revenue by Application (2021-2032)
  11. 5.3.3 Global Albendazole Tablets Revenue Market Share by Application (2021-2032)
6 Global Albendazole Tablets Sales by Region
  1. 6.1 Global Albendazole Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albendazole Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Albendazole Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Albendazole Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Albendazole Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Albendazole Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Albendazole Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Albendazole Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Albendazole Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Albendazole Tablets Revenue by Region
  1. 7.1 Global Albendazole Tablets Revenue by Region
  2. 7.1.1 Global Albendazole Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Albendazole Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Albendazole Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Albendazole Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Albendazole Tablets Revenue (2021-2032)
  8. 7.2.2 North America Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Albendazole Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Albendazole Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Albendazole Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Albendazole Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  2. 8.1.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  3. 8.1.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  4. 8.1.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Product Portfolio
  6. 8.1.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
  7. 8.2 Zhejiang Anbet Pharmaceutical Co., Ltd.
  8. 8.2.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  12. 8.2.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Sichuan Tiande Pharmaceutical Co., Ltd.
  14. 8.3.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  18. 8.3.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  20. 8.4.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
  21. 8.4.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
  22. 8.4.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Product Portfolio
  24. 8.4.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
  25. 8.5 Sancai Shiqi Pharmaceutical Co., Ltd.
  26. 8.5.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  30. 8.5.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Ningxia Qiyuan National Pharmaceutical Co., Ltd.
  32. 8.6.1 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  36. 8.6.5 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Longhui Pharmaceutical Co., Ltd.
  38. 8.7.1 Longhui Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Longhui Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  42. 8.7.5 Longhui Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Huazhong Pharmaceutical Co., Ltd.
  44. 8.8.1 Huazhong Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Huazhong Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  48. 8.8.5 Huazhong Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Hubei Ruihua Pharmaceutical Co., Ltd.
  50. 8.9.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  54. 8.9.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Hubei Meibao Pharmaceutical Co., Ltd.
  56. 8.10.1 Hubei Meibao Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Hubei Meibao Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  60. 8.10.5 Hubei Meibao Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Hubei Kelun Pharmaceutical Co., Ltd.
  62. 8.11.1 Hubei Kelun Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Hubei Kelun Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  66. 8.11.5 Hubei Kelun Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hubei Guangji Pharmaceutical Co., Ltd.
  68. 8.12.1 Hubei Guangji Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hubei Guangji Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  72. 8.12.5 Hubei Guangji Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Henan Runhong Pharmaceutical Co., Ltd.
  74. 8.13.1 Henan Runhong Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Henan Runhong Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  78. 8.13.5 Henan Runhong Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Hangzhou Minsheng Pharmaceutical Co., Ltd.
  80. 8.14.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  84. 8.14.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guangzhou Kanghe Pharmaceutical Co., Ltd.
  86. 8.15.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  90. 8.15.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Anhui Shengying Pharmaceutical Co., Ltd.
  92. 8.16.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  96. 8.16.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Teva
  98. 8.17.1 Teva Company Information
  99. 8.17.2 Teva Business Overview
  100. 8.17.3 Teva Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Teva Albendazole Tablets Product Portfolio
  102. 8.17.5 Teva Recent Developments
  103. 8.18 Sequent Scientific
  104. 8.18.1 Sequent Scientific Company Information
  105. 8.18.2 Sequent Scientific Business Overview
  106. 8.18.3 Sequent Scientific Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sequent Scientific Albendazole Tablets Product Portfolio
  108. 8.18.5 Sequent Scientific Recent Developments
  109. 8.19 Salius Pharma
  110. 8.19.1 Salius Pharma Company Information
  111. 8.19.2 Salius Pharma Business Overview
  112. 8.19.3 Salius Pharma Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Salius Pharma Albendazole Tablets Product Portfolio
  114. 8.19.5 Salius Pharma Recent Developments
  115. 8.20 Lasa Supergenerics Limited
  116. 8.20.1 Lasa Supergenerics Limited Company Information
  117. 8.20.2 Lasa Supergenerics Limited Business Overview
  118. 8.20.3 Lasa Supergenerics Limited Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Lasa Supergenerics Limited Albendazole Tablets Product Portfolio
  120. 8.20.5 Lasa Supergenerics Limited Recent Developments
  121. 8.21 K.A. Malle Pharmaceuticals
  122. 8.21.1 K.A. Malle Pharmaceuticals Company Information
  123. 8.21.2 K.A. Malle Pharmaceuticals Business Overview
  124. 8.21.3 K.A. Malle Pharmaceuticals Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 K.A. Malle Pharmaceuticals Albendazole Tablets Product Portfolio
  126. 8.21.5 K.A. Malle Pharmaceuticals Recent Developments
  127. 8.22 GlaxoSmithKline
  128. 8.22.1 GlaxoSmithKline Company Information
  129. 8.22.2 GlaxoSmithKline Business Overview
  130. 8.22.3 GlaxoSmithKline Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 GlaxoSmithKline Albendazole Tablets Product Portfolio
  132. 8.22.5 GlaxoSmithKline Recent Developments
  133. 8.23 Fredun Pharmaceuticals Ltd
  134. 8.23.1 Fredun Pharmaceuticals Ltd Company Information
  135. 8.23.2 Fredun Pharmaceuticals Ltd Business Overview
  136. 8.23.3 Fredun Pharmaceuticals Ltd Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Fredun Pharmaceuticals Ltd Albendazole Tablets Product Portfolio
  138. 8.23.5 Fredun Pharmaceuticals Ltd Recent Developments
  139. 8.24 AdvaCare Pharma
  140. 8.24.1 AdvaCare Pharma Company Information
  141. 8.24.2 AdvaCare Pharma Business Overview
  142. 8.24.3 AdvaCare Pharma Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 AdvaCare Pharma Albendazole Tablets Product Portfolio
  144. 8.24.5 AdvaCare Pharma Recent Developments
  145. 8.25 Aden
  146. 8.25.1 Aden Company Information
  147. 8.25.2 Aden Business Overview
  148. 8.25.3 Aden Albendazole Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Aden Albendazole Tablets Product Portfolio
  150. 8.25.5 Aden Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albendazole Tablets Value Chain Analysis
  2. 9.1.1 Albendazole Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albendazole Tablets Production Mode & Process
  6. 9.2 Albendazole Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albendazole Tablets Distributors
  9. 9.2.3 Albendazole Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst